A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment | MicrobiomeTrials← Back to trialsNCT07025811
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
CompletedPHASE4INTERVENTIONAL
Trial Details
Start: 2025-07-09Est. Completion: 2026-07-16
Enrollment target: 378 participants Locations- Eye Research Foundation, Newport Beach, California, United States
- Butchertown Clinical Trials, Louisville, Kentucky, United States
- Andover Eye Associates, Andover, Massachusetts, United States
- Oculus Research, Garner, North Carolina, United States
- CORE Inc., Shelby, North Carolina, United States
- Advancing Vision Research, LLC, Goodlettsville, Tennessee, United States
- Total Eyecare, P.A., Memphis, Tennessee, United States
- Piedmont Eye Center, Lynchburg, Virginia, United States
Other microbiome trials you might be interested in
Age-Related Macular Degeneration
The main objective of the study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-deri…
San Francisco, United StatesEst. completion Dec 31, 2021
HyperpigmentationDry SkinErythema
The purpose of this study is to evaluate the efficacy and safety of MB Luxury skincare containing the active ingredient …
Semarang, IndonesiaCompleted Mar 1, 2026